Two Dose Levels of Privigen in Pediatric CIDP

Clinical trial NCT03684018 · RECRUITING

Trial details

NCT number: NCT03684018
Sponsor: CSL Behring
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Start date: 2019-02-28
Primary completion: 2029-12-20
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.